文献摘要信息 ,CTPI)扫描,计算肝动脉灌注量(HEPATIC ARTERIAL PERFUSION,HAP)、门静脉灌注量(PORTAL VEIN PERFUSION,PVP)、总肝灌注量(TOTAL LIVER PERFUSION,TLP),对照分析不同时间LIPO-PGE
基于4个网页-相关网页
...-论文-考试吧 ),根据所得数据计算出肝动脉灌流量(hepatic arterial persusion,HAP)、门静脉灌流量(portal vein perfusion,PVP),HAP=HBF×HAF,PVP=HBF×(1HAF)。
基于4个网页-相关网页
肝动脉灌注量(hepaticarteryperfusionHAP) 和门静脉灌注量(portal vein perfusion,PVP)的计算采用公式(HAP=HBF×HAF和 PVP=HBF.RAP)在Excel表格中计算完成。
基于2个网页-相关网页
portal vein perfusion index 门静脉灌流指数 ; 及门脉灌注指数 ; 门静脉灌注指数 ; 门脉灌注指数
CONCLUSIONS Intra indirect portal vein perfusion can be apply to dual perfusion treatment of liver tumors as a supplementing means of portal vein perfusion.
结论:经间接门静脉灌注可作为直接门静脉灌注的一个补充手段应用于肝肿瘤的“双灌注”治疗。
Conclusion: Chronic hepatitis gravis is apt to form acute portal hypertension with decreased perfusion of portal vein system thus causing liver in a state of lacking of blood and oxygen.
结论:慢性重型肝炎容易形成门静脉高压,门静脉血流灌注量明显减少,造成肝脏微循环障碍。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
应用推荐